What blood tests should be ordered for a patient with hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Tests to Order for Hypercalcemia

Order intact parathyroid hormone (iPTH) as the single most important initial test, along with serum calcium (total and ionized), albumin, phosphorus, creatinine, and magnesium; then proceed to second-line tests including 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and PTHrP based on the PTH result. 1, 2, 3

First-Line Laboratory Tests (Order These Initially)

Essential Core Panel

  • Serum calcium (both total and ionized) to confirm and quantify hypercalcemia 1, 2, 3
  • Albumin to calculate corrected calcium using the formula: corrected calcium (mg/dL) = total calcium (mg/dL) - 0.8 × [albumin (g/dL) - 4] 2, 3
  • Intact parathyroid hormone (iPTH) - this is the most critical test to differentiate PTH-dependent from PTH-independent causes 1, 2, 3, 4
  • Serum phosphorus - typically low in primary hyperparathyroidism and high in vitamin D toxicity 2
  • Serum creatinine and blood urea nitrogen to assess renal function 1, 2, 3
  • Magnesium level 1, 2

Important Sampling Considerations

  • Obtain fasting samples for diagnostic purposes, as calcium supplements or calcium-containing nutrients can cause transient elevations lasting several hours 5
  • Avoid prolonged venous stasis during blood draw, as this causes hemoconcentration and artificially elevates the bound calcium fraction 5

Second-Line Tests (Based on PTH Results)

If PTH is Elevated or Inappropriately Normal (Suggests Primary Hyperparathyroidism)

  • 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels - measure both together as their relationship provides critical diagnostic information 6, 1, 2
  • Consider renal ultrasound to assess for nephrocalcinosis or nephrolithiasis 2
  • Consider bone mineral density testing 2

If PTH is Suppressed (<20 pg/mL) (Suggests Non-PTH Mediated Causes)

  • Parathyroid hormone-related protein (PTHrP) to evaluate for humoral hypercalcemia of malignancy 1, 2, 3, 4
  • 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D if granulomatous disease (such as sarcoidosis) is suspected 6, 2
  • Consider chest X-ray and age-appropriate cancer screening 2

Clinical Context and Pitfalls

Severity Classification

Classify hypercalcemia severity to guide urgency: mild (>10 to <11 mg/dL), moderate (11 to 12 mg/dL), or severe (>14 mg/dL) 1, 3, 4

Common Diagnostic Errors to Avoid

  • Do not rely on corrected calcium formulas alone - they may be accurate only within a limited range and can introduce errors; ionized calcium is more reliable for diagnostic purposes 5
  • Interpret PTH cautiously in renal insufficiency - secondary hyperparathyroidism may coexist with other causes of hypercalcemia 1, 3
  • Always measure both vitamin D metabolites together (25-hydroxyvitamin D and 1,25-dihydroxyvitamin D) rather than individually, as the American Thoracic Society emphasizes their relationship provides critical diagnostic information 6, 1

Special Populations

  • In suspected sarcoidosis, baseline serum calcium testing is recommended even without symptoms, as hypercalcemia occurs in approximately 6% of patients, with elevated 1,25-dihydroxyvitamin D due to increased 1α-hydroxylase production in granulomas 1, 3
  • In malignancy-associated hypercalcemia, expedite the diagnostic evaluation as it may indicate advanced disease with poor prognosis (median survival approximately 1 month after discovery in lung cancer) 2

Underlying Causes

Primary hyperparathyroidism and malignancy account for more than 90% of hypercalcemia cases 4, 7

References

Guideline

Diagnostic Approach for Hypercalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Workup for Hypercalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypercalcemia Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Calcium metabolism & hypercalcemia in adults.

Current medicinal chemistry, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.